Ads
related to: how to treat mucopolysaccharidosis skin care options
Search results
Results From The WOW.Com Content Network
Hyaluronidase deficiency, also known as Mucopolysaccharidosis type IX or MPS IX, is a condition caused by mutations in the HYAL1 gene, and is characterized by multiple soft-tissue masses. [ 1 ] : 544
Medical care is directed at treating systemic conditions and improving the person's quality of life. Physical therapy and daily exercise may delay joint problems and improve the ability to move. Changes to the diet will not prevent disease progression, but limiting milk, sugar, and dairy products has helped some individuals experiencing ...
Mucopolysaccharidosis type I is a spectrum of diseases in the mucopolysaccharidosis family. It results in the buildup of glycosaminoglycans (or GAGs, or mucopolysaccharides) due to a deficiency of alpha-L iduronidase , an enzyme responsible for the degradation of GAGs in lysosomes .
Maroteaux–Lamy syndrome, or Mucopolysaccharidosis Type VI (MPS-VI), is an inherited disease caused by a deficiency in the enzyme arylsulfatase B (ARSB). [3] ASRB is responsible for the breakdown of large sugar molecules called glycosaminoglycans (GAGs, also known as mucopolysaccharides).
This reduces the treatment time, makes the treatment more effective, and enables the use of a weaker psoralen. The physician and physiotherapists can choose a starting dose of UV based on the patient's skin type. The UV dose will be increased in every treatment until the skin starts to respond, normally when it becomes a little bit pink.
A critical aspect of treatment is paying close attention to how your skin reacts to various conditions, situations, and products. This helps you avoid triggers and better manage your atopic eczema ...